Desidustat

德昔度司他

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameDesidustat
Drug Alias Name德度司他OxemiaZYAN-1ZYAN1-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Anemia
Global Approved IndicationsAnemia
Approved Indications in ChinaAnemia
Original Approved Country/TerritoryIndia
Original Approved Date2022/03/03
Country/TerritoryMexicoIndiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZydus Cadila
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChina Medical System Holdings LtdZydus Lifesciences LtdKangzhe (Hunan) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksWikipedia